MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]
Peer-reviewed trial results demonstrate robust bacterial reduction without resistance in [...]
MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]
Peer-reviewed trial results demonstrate robust bacterial reduction without resistance in [...]